These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26856795)

  • 1. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.
    Egan BM; Kai B; Wagner CS; Henderson JH; Chandler AH; Sinopoli A
    J Clin Hypertens (Greenwich); 2016 Aug; 18(8):817-24. PubMed ID: 26856795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
    Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
    Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.
    Akinyelure OP; Sakhuja S; Colvin CL; Clark D; Jaeger BC; Hardy ST; Howard G; Cohen LP; Irvin MR; Tanner R; Carey RM; Muntner P
    Hypertension; 2020 Dec; 76(6):1953-1961. PubMed ID: 33131312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
    de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
    Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
    Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
    J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
    Egan BM; Zhao Y; Axon RN; Brzezinski WA; Ferdinand KC
    Circulation; 2011 Aug; 124(9):1046-58. PubMed ID: 21824920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
    Bakris G; Lin PP; Xu C; Chen C; Ashton V; Singhal M
    J Clin Hypertens (Greenwich); 2024 May; 26(5):500-513. PubMed ID: 38523465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
    Langford AT; Akinyelure OP; Moore TL; Howard G; Min YI; Hillegass WB; Bress AP; Tajeu GS; Butler M; Jaeger BC; Yano Y; Shimbo D; Ogedegbe G; Calhoun D; Booth JN; Muntner P
    Hypertension; 2020 Nov; 76(5):1600-1607. PubMed ID: 32924633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study.
    Akinyelure OP; Jaeger BC; Safford MM; Oparil S; Carson AP; Sims A; Hannon L; Howard G; Muntner P; Hardy ST
    J Am Heart Assoc; 2024 May; 13(10):e031695. PubMed ID: 38752519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.
    Shallcross AJ; Butler M; Tanner RM; Bress AP; Muntner P; Shimbo D; Ogedegbe G; Sims M; Spruill TM
    J Hum Hypertens; 2017 Jul; 31(7):474-478. PubMed ID: 28124682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
    Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana.
    Sarfo FS; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105401. PubMed ID: 33096498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
    Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
    Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care fragmentation and blood pressure control among adults taking antihypertensive medication.
    Colvin CL; Safford MM; Muntner P; Colantonio LD; Kern LM
    Am J Manag Care; 2022 Mar; 28(3):108-115. PubMed ID: 35404546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
    Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
    J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
    Irvin MR; Booth JN; Sims M; Bress AP; Abdalla M; Shimbo D; Calhoun DA; Muntner P
    J Clin Hypertens (Greenwich); 2018 Mar; 20(3):438-446. PubMed ID: 29436105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.